Increased islet apoptosis in Pdx1+/- mice

Journal of Clinical Investigation

Volumn 111, Issue 8, 2003, Pages 1147-1160

  Johnson, James D ^a   Ahmed, Noreen T ^b   Luciani, Dan S ^a   Han, Zhiqiang ^a   Tran, Hung ^a   Fujita, Jun ^a   Misler, Stanley ^a   Edlund, Helena ^c   Polonsky, Kenneth S ^a,d  

^a BARNES JEWISH HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALCIUM ION; CASPASE 3; GLUCOSE; INSULIN; POTASSIUM CHLORIDE; PROTEIN BCL 2; PROTEIN BCL X; TRANSCRIPTION FACTOR PDX 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; DEPOLARIZATION; DIABETES MELLITUS; EXOCYTOSIS; FEMALE; GLUCOSE TOLERANCE; HOMEOBOX; IN VIVO STUDY; INSULIN RELEASE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CALCIUM SIGNALING; EXOCYTOSIS; FEMALE; GLUCOSE TOLERANCE TEST; HOMEODOMAIN PROTEINS; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; PERFUSION; TRANS-ACTIVATORS;

EID: 0242584873     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200316537     Document Type: Article

References (66)

1. Sommer, R.J., et al. 1998. The Pristionchus HOX gene Ppa-lin-39 inhibits programmed cell death to specify the vulva equivalence group and is not required during vulval induction. Development. 125:3865-3873.
2. Rhinn, M., Dierich, A., Le Meur, M., and Ang, S. 1999. Cell autonomous and non-cell autonomous functions of Otx2 in patterning the rostral brain. Development. 126:4295-4304.
3. Izon, D.J., et al. 1998. Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes. Blood. 92:383-393.
4. Dear, T.N., et al. 1995. The Hox11 gene is essential for cell survival during spleen development. Development. 121:2909-2915.
5. Offield, M.F., et al. 1996. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development. 122:983-995.
6. Jonsson, J., Carlsson, L., Edlund, T., and Edlund, H. 1994. Insulinpromoter-factor 1 is required for pancreas development in mice. Nature. 371:606-609.
7. Stoffers, D.A., Zinkin, N.T., Stanojevic, V., Clarke, W.L., and Habener, J.F. 1997. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15:106-110.
8. McKinnon, C.M., and Docherty, K. 2001. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 44:1203-1214.
9. Dutta, S., Bonner-Weir, S., Montminy, M., and Wright, C. 1998. Regulatory factor linked to late-onset diabetes? Nature. 392:560.
10. Lottmann, H., Vanselow, J., Hessabi, B., and Walther, R. 2001. The Tet-On system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic beta-cells. J. Mol. Med. 79:321-328.
11. Ahlgren, U., Jonsson J., Jonsson, L., Simu, K., and Edlund, H. 1998. beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12:1763-1768.
12. Thomas, M.K., et al. 2001. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J. Clin. Invest. 108:319-329. doi:10.1172/JCI200112029.
13. Brissova, M., et al. 2002. Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J. Biol. Chem. 227:11225-11232.
14. Chakrabarti, S.K., James, J.C., and Mirmira, R.G. 2002. Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem. 277:13286-13293.
15. Ohlsson, H., Karlsson, K., and Edlund, T. 1993. IPF1, a homeodomaincontaining transactivator of the insulin gene. EMBO J. 12:4251-4259.
16. Setup, P., et al. 1996. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc. Natl. Acad. Sci U. S. A. 93:9015-9020.
17. Macfarlane, W.M., et al. 2000. Glucose regulates islet amyloid polypeptide gene transcription in a PDX1- and calcium-dependent manner. J. Biol. Chem. 275:15330-15335.
18. Watada, H., et al. 1996. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes. 45:1478-1488.
19. Waeber, G., Thompson, N., Nicod, P., and Bonny, C. 1996. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol. Endocrinol. 10:1327-1334.
20. Bonner-Weir, S. 2000. Perspective: postnatal pancreatic beta cell growth. Endocrinology 141:1926-1929.
21. Pontoglio, M., et al. 1998. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J. Clin. Invest. 101:2215-2222.
22. Lacy, P.E., and Kostianovsky, M. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 16:35-39.
23. Zhou, Y.P., et al. 2000. Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am. J. Physiol. Endocrinol. Metab. 278:E340-E351.
24. Grynkiewicz, G., Poenie, M., and Tsien, R.Y. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
25. Johnson, J.D., Van Goor, F., Wong, C.J., Goldberg, J.I., and Chang, J.P. 1999. Two endogenous gonadotropin-releasing hormones generate dissimilar Ca(2+) signals in identified goldfish gonadotropes. Gen. Comp. Endocrinol. 116:178-191.
26. Barnett, D.W., and Misler, S. 1997. An optimized approach to membrane capacitance estimation using dual-frequency excitation. Biophys. J. 72:1641-1658.
27. Zhou, Y.P., et al. 1998. Apoptosis in insulin-secreting cells. Evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. J. Clin. Invest. 101:1623-1632.
28. Fadok, V.A., et al. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
29. Wong, H., Anderson, W.D., Cheng, T., and Riabowol, K.T. 1994. Monitoring mRNA expression by polymerase chain reaction: the "primerdropping" method. Anal. Biochem. 223:251-258.
30. Gillis, K.D., and Misler, S. 1993. Enhancers of cytosolic cAMP augment depolarization-induced exocytosis from pancreatic B-cells: evidence for effects distal to Ca2+ entry. Pflugers Arch. 424:195-197.
31. Raman, V., et al. 2000. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature. 405:974-978.
32. Quaggin, S.E., Yeger, H., and Igarashi, P. 1997. Antisense oligonucleotides to Cux-1, a Cut-related homeobox gene, cause increased apoprosis in mouse embryonic kidney cultures. J Clin. Invest. 99:718-724.
33. Shimamoto, T., Nakamura, S., Bollekens, J., Ruddle, F.H., and Takeshita, K. 1997. Inhibition of DLX-7 homeobox gene causes decreased expression of GATA-1 and c-myc genes and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94:3245-3249.
34. Shimamoto, T., Ohyashiki, K., and Takeshita, K. 2000. Overexpression of the homeobox gene DLX-7 inhibits apoptosis by induced expression of intercellular adhesion molecule-1. Exp. Hematol. 28:433-441.
35. Leibowitz, G., et al. 2001. IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal with type 2 diabetes. Diabetes. 50:1799-1806.
36. Leibowitz, G., et al. 2001. Beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes. Diabetes. 50:S113-S117.
37. Donath, M.Y., Gross, D.J., Cerasi, E., and Kaiser, N. 1999. Hyperglycemiainduced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes. 48:738-744.
38. Seufert, J., Weir, G.C., and Habener, J.F. 1998. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein β and transactivator islet duodenum homeobox-1 in rat pancreatic β cells during the development of diabetes mellitus. J. Clin. Invest. 101:2528-2539.
39. Harmon, J.S., et al. 1999. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes. 48:1995-2000.
40. Stoffers, D.A., et al. 2000. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes. 49:741-748.
41. Marshak, S., et al. 1999. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes. 48:1230-1236.
42. Gremlich, S., Bonny, C., Waeber, G., and Thorens, B. 1997. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol Chem. 272:30261-30269.
43. Cnop, M., Hannaert, J.C., Hoorens, A., Eizirik, D.L., and Pipeleers, D.G. 2001. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes. 50:1771-1777.
44. Olson, L.K., et al. 1995. Reduction of insulin gene transcription in Hit-T15 beta cells chronically exposed to a supraphysiological glucose concentration is associated with loss of STF-1 transcription factor expression. Proc. Natl. Acad. Sci. U. S. A. 92:9127-9131.
45. Sharma, A., Olson, L.K., Robertson, R.P., and Stein, R. 1995. The reduction of insulin gene transcription in Hit-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol. Endocrinol. 9:1127-1134.
46. Zangen, D.H., et al. 1997. Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy. Diabetes. 46:258-264.
47. Stoffers, D.A., Ferrer, J., Clarke, W.L., and Habener, J.F. 1997. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17:138-139.
48. Hani, E.H., et al. 1999. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J. Clin. Invest. 104:R41-R48.
49. Macfarlane, W.M., et al. 1999. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J. Clin. Invest. 104:R33-R39.
50. Johnson, J. D., and Chang, J.P. 2000. Function- and agonist-specific Ca2+ signalling: the requirement for and mechanism of spatial and temporal complexity in Ca2+ signals. Biochem. Cell Biol. 78:217-240.
51. Berridge, M.J., Bootman, M. D., and Lipp, P. 1998. Calcium - a life and death signal. Nature. 395:645-648.
52. Nakai, J., et al. 2002. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32:245-253.
53. Wu, H., et al. 1999. Insulin stimulates pancreatic-duodenal homoeobox factor-1 (PDX1) DNA-binding activity and insulin promoter activity in pancreatic beta cells. Biochem. J. 344:813-818.
54. Kushner, J.A., et al. 2002. Pdx1 restores β cell function in Irs2 knockout mice. J. Clin. Invest. 109:1193-1201. doi:10.1172/JCI200214439.
55. Shih, D.Q., et al. 2002. Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta. Proc. Natl. Acad. Sci. U. S. A. 99:3818-3823.
56. Macfarlane, W.M., et al. 1999. Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells. J. Biol. Chem. 274:1011-1016.
57. Elrick, L.J., and Docherty, K. 2001. Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1. Diabetes. 50:2244-2252.
58. Macfarlane, W.M., et al. 2000. Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes. 49:418-423.
59. Ferber, S., et al. 2000. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6:568-572.
60. Glick, E., Leshkowitz, D., and Walker, M.D. 2000 Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J. Biol. Chem. 275:2199-2204.
61. Beattie, G.M., et al. 1999. Sustained proliferation of PDX-1(+) cells derived from human islets. Diabetes. 48:1013-1019.
62. Kajimoto, Y., et al. 1997. Suppression of transcription factor PDX-1/IPE1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells. J. Clin. Invest. 100:1840-1846.
63. Nakamura, T., et al. 2001. Insulin production in a neuroectodermal tumor that expresses islet factor-1, but not pancreatic-duodenal homeobox 1. J. Clin. Endocrinol. Metab. 86:1795-1800.
64. Kawaguchi, Y., et al. 2002. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 32:128-134.
65. MacFarlane, W.M., et al. 1999. Engineering a glucose-responsive human insulin-secreting cell line from islets of Langerhans isolated from a patient with persistent hyperinsulinemic hypoglycemia of infancy. J. Biol. Chem. 274:34059-34066.
66. Wobser, H., et al. 2002. Dominant-negative suppression of HNF-1 alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death. J. Biol. Chem. 277:6413-6421.